abstract |
The present invention relates to the diagnosis, prognosis, progression, and treatment of Alzheimer's disease. In particular, Alzheimer's disease can be characterized by the differential expression of certain genes, including ASB9, BIK, C7orfl6, NDP, NLRP2, PLPl, SLC45A2, TBX2, TUBB4, ZNF300, ADM2, FLJ35024, MT2A, PTGS2, ABCC2, ECELl, EGFL8, FSTL5, and SMOC1. The present invention also relates to systems and methods of analyzing Alzheimer's disease, methods of screening for treatment agents for Alzheimer's disease and kits for the analysis of Alzheimer's disease. |